Cargando…
Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction
BACKGROUND: The standardization for the clinical use of drug therapy for cerebral infarction (CI) has not yet determined in some aspects. In this paper, we discussed the efficacies of different drug therapies (aspirin, aspirin plus dipyridamole, aspirin plus clopidogrel, aspirin plus warfarin, cilos...
Autores principales: | Zhang, Jian-Jun, Liu, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895377/ https://www.ncbi.nlm.nih.gov/pubmed/29595635 http://dx.doi.org/10.1097/MD.0000000000010123 |
Ejemplares similares
-
Evaluation of efficacy and safety of aspirin combination treatment in treating patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Wang, Xueling, et al.
Publicado: (2022) -
Do Glioma Patients Derive Any Therapeutic Benefit From Taking a Higher Cumulative Dose of Temozolomide Regimens?: A Meta-Analysis
por: Sun, Hao, et al.
Publicado: (2015) -
Topiramate-related adverse events: Pattern and signals in the Korea Adverse Event Reporting System, 2010-2017
por: Choi, Junyeong, et al.
Publicado: (2020) -
Methylphenidate has mild hyperglycemic and hypokalemia effects and increases leukocyte and neutrophil counts
por: Charach, Gideon, et al.
Publicado: (2020) -
Adverse reactions of vancomycin in humans: A protocol for meta-analysis
por: Peng, Yang, et al.
Publicado: (2020)